891494-65-8 Usage
Description
1-BOC-BETA-OXO-3-PIPERIDINEPROPANOIC ACID METHYL ESTER is a versatile chemical compound utilized in synthetic organic chemistry. It is a methyl ester derivative of BOC-BETA-OXO-3-PIPERIDINEPROPANOIC ACID, a compound with applications in medicinal chemistry. The BOC group, or tert-butyloxycarbonyl, serves as a protecting group for amines in organic synthesis, preventing unwanted reactions. 1-BOC-BETA-OXO-3-PIPERIDINEPROPANOIC ACID METHYL ESTER's reactivity and versatility make it a valuable building block in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. Due to its potential hazardous nature, it is crucial to handle this compound with care and follow proper safety protocols.
Uses
Used in Pharmaceutical Industry:
1-BOC-BETA-OXO-3-PIPERIDINEPROPANOIC ACID METHYL ESTER is used as a building block for the synthesis of various pharmaceuticals, contributing to the development of new medications and therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical sector, 1-BOC-BETA-OXO-3-PIPERIDINEPROPANOIC ACID METHYL ESTER is employed as a component in the creation of agrochemicals, potentially enhancing crop protection and yield.
Used in Organic Synthesis:
1-BOC-BETA-OXO-3-PIPERIDINEPROPANOIC ACID METHYL ESTER is used as a versatile reagent in organic synthesis, enabling the formation of a wide range of organic compounds for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 891494-65-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,1,4,9 and 4 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 891494-65:
(8*8)+(7*9)+(6*1)+(5*4)+(4*9)+(3*4)+(2*6)+(1*5)=218
218 % 10 = 8
So 891494-65-8 is a valid CAS Registry Number.
891494-65-8Relevant articles and documents
HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS
-
Page/Page column 32; 132; 138, (2019/01/17)
Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
2-FLUOROPYRAZOLO[1,5-A]PYRIMIDINES AS PROTEIN KINASE INHIBITORS
-
Page/Page column 60, (2009/07/03)
Pyrazolo[1,5-a]pyrimidine-based inhibitors of various kinase, compositions including the inhibitors, and methods of using the inhibitors and inhibitor compositions are described. The inhibitors and compositions that contain such inhibitors are useful for treating disease or disease symptoms. The invention also provides for methods of making CDK-2 or CHK-1 inhibitor compounds, methods of inhibiting CDK-2 or CHK-1, and methods for treating disease or disease symptoms.
Methods for inhibiting protein kinases
-
Page/Page column 95; 112, (2010/11/26)
The present invention provides methods for inhibiting protein kinases selected from the group consisting of AKT, Checkpoint kinase, Aurora kinase, Pim kinases, and tyrosine kinase using pyrazolo[1,5-a]pyrimidine compounds and methods of treatment, prevent
